Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

NRX Pharmaceuticals Inc (NRXP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow NRX Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.120 +0.070    +2.30%
24/04 - Closed. Currency in USD ( Disclaimer )
After Hours
3.050
-0.070
-2.244%
0:52:27 - Real-time Data
  • Volume: 94,137
  • Bid/Ask: 2.960 / 3.150
  • Day's Range: 3.040 - 3.185
Type:  Equity
Market:  United States
NRX Pharmaceuticals 3.120 +0.070 +2.30%

NRX Pharmaceuticals Company Profile

 
Read the NRX Pharmaceuticals Inc company profile to learn more about the business and the management team. View NRX Pharmaceuticals Inc facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

ORD

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned FDA-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior. The company has a partnership with Alvogen Inc. and Lotus Pharmaceutical Company; development and manufacturing agreement with Nephron Pharmaceuticals, Inc. and Alcami; license agreement with Apkarian Technologies; development and license agreement with Glytech; license agreement with Sarah Herzog Memorial Hospital. The company was founded in 2015 and is based in Wilmington, Delaware.

Contact Information

Address 1201 Orange Street Suite 600
Wilmington, 19801
United States
Phone 484-254-6134
Fax -

Top Executives

Name Age Since Title
Chaim Hurvitz 61 2021 Independent Director
Jonathan C. Javitt 67 2021 Co-Founder, Chief Scientist Officer & Chairman
Chaim Hurvitz 63 2021 Independent Director
Patrick John Flynn 74 2021 Independent Director
Stephen H. Willard 63 2022 Acting Corporate Secretary, CEO & Director
Janet Rehnquist 66 2023 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NRXP Price Commentary

Write your thoughts about NRX Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Peter Owt
Peter Owt Nov 29, 2021 14:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
New test results show 2.5 times more successful than current COVID / respiratory treatments.
Peter Owt
Peter Owt Nov 29, 2021 14:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
New results showing 2.5 times more successful thsn other current post Covid respiratory treatments. 🚀🚀
Peter Owt
Peter Owt Nov 29, 2021 13:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Over $20 again?
Peter Owt
Peter Owt Nov 23, 2021 14:42
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Loading up for the next run up
Omid Take
Omid Take Jun 21, 2021 19:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock will go down all broker don't have CFDs to sell stock
Peetu Palo
Peetu Palo Dec 22, 2020 13:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why this sprint is going on?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email